Biotech news for Sunday, May 31, 2026, ranked by our 5-dimension investment framework — regulatory, technology, commercial, manufacturing, and narrative.
tang90246 The US FDA has approved AbbVie's ( ABBV ) Decnupaz ( pivekimab sunirine) for blastic plasmacytoid dendritic cell neoplasm (BPDCN), an ultra-rare hematologic malignancy. The CD123-directed antibody and alkylating agent conjugate comes with a boxed war…
gracethang/iStock via Getty Images Although it met all primary and secondary endpoints, Apogee Therapeutics ( APGE ) is down Wednesday afternoon following the release of data from a phase 2 trial of zumilokibart for atopic dermatitis. Separately, Apogee said i…
Dmitry Vinogradov Shares of PTC Therapeutics ( PTCT ) ended a three-day decline on Wednesday after Jefferies upgraded the stock to Buy from Hold, expecting the rare disease drugmaker to beat consensus estimates thanks to its phenylketonuria therapy, Sephience.…
Ironwood Pharmaceuticals ( IRWD ) announced on Wednesday that the Food and Drug Administration approved a label expansion for its AbbVie ( ABBV )-partnered bowel disorder therapy Linzess to treat children with functional constipation. Launched in 2022, Linzess…